
Inflammation Predicts Immunotherapy Success in Lung Cancer
The Prognostic Power of Systemic Inflammation in Immunotherapy for Non-Small Cell Lung Cancer: New Meta-Analytical Insights Lung cancer remains a formidable challenge in oncology, ranking as the second most common malignancy worldwide following breast …